Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03422419

TIPS or Anticoagulation in Portal Vein Thrombosis

An Investigator-initiated, Multicentre, Randomized, Trial Comparing Anticoagulation Alone Versus Transjugular Intrahepatic Portosystemic Shunt (TIPS) and Anticoagulation in Patients With Recent Obstructive Portal Vein Thrombosis

Status
Withdrawn
Phase
Phase 3
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Insel Gruppe AG, University Hospital Bern · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The PROGRESS is an investigator-initiated, multicentre, randomized, trial comparing anticoagulation, which is the currently most frequently used treatment, alone, versus transjugular intrahepatic portosystemic shunt (TIPS) combined with anticoagulation, in patients presenting with recent obstructive portal vein thrombosis (ROPVT). The rationale of this study is to significantly increase the proportion of patients that achieve a complete or partial recanalization of the portal vein. The intervention of this study consists in TIPS deployment and catheter based clot removal in addition to anticoagulation. The investigators retain that this intervention will increase the proportion of patients with an open portal vein from 38% with anticoagulation alone to 83% with anticoagulation and TIPS after 6 months. Both anticoagulant therapy and clot removal/TIPS are treatments that are currently available and accepted indications for the treatment of ROPVT. Anticoagulation will be performed with unfractioned heparin or low molecular weight heparin initially and with vitamin K antagonists in the long term. The investigators plan to collect blood for biobanking at the time of inclusion and after 6 months. Blood samples for a biobank will be collected.

Conditions

Interventions

TypeNameDescription
DRUGHeparinThe choice of the anticoagulant medication in terms of duration and dose will be determined by the treating physician.
DEVICETIPStransjugular intrahepatic portosystemic shunt deployment

Timeline

Start date
2018-08-01
Primary completion
2020-10-31
Completion
2021-07-31
First posted
2018-02-05
Last updated
2018-11-01

Source: ClinicalTrials.gov record NCT03422419. Inclusion in this directory is not an endorsement.